The impact of an intensive antimicrobial control program in a Taiwanese medical center

Pharmacy World and Science

Volumn 28, Issue 4, 2006, Pages 257-264

  Chang, Ming Tsung ^a,b   Wu, Tzu Hua ^b   Wang, Chun Yu ^a   Jang, Tsrang Neng ^a   Huang, Chien Yu ^b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial control program; Inpatients; Parenteral antimicrobials; Rationalized antimicrobial usage; Susceptibility; Taiwan

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFAZOLIN; CEFMETAZOLE; CEFTIZOXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; ISEPAMICIN; MACROLIDE; MINOCYCLINE; NETILMICIN; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; TIMENTIN; UNINDEXED DRUG;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH CENTER; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; INFECTION CONTROL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; SERRATIA; TAIWAN;

ADULT; AGED; AMINOGLYCOSIDES; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CEPHALOSPORINS; CROSS INFECTION; DRUG COSTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION REVIEW; ECONOMICS, HOSPITAL; ERYTHROMYCIN; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; QUINOLONES; TAIWAN; TETRACYCLINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33750561476     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9035-5     Document Type: Article

References (29)

1. Ho M, Hsiung CA, Yu HT, Chi CL, Chang HJ. Changes before and after a policy to restrict antimicrobial usage in upper respiratory infections in Taiwan. Int J Antimicrob Agents 2004;23:438-45.
2. Kunin CM. Resistance to antimicrobial drugs-a worldwide calamity. Ann Intern Med 1993;118:557-61.
3. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851-3.
4. Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 1999;31:191-5.
5. Mazzeo F, Capuano A, Avolio A, Filippelli A, Rossi F. Hospital-based intensive monitoring of antibiotic-induced adverse events in a university hospital. Pharmacol Res 2005;51:269-74.
6. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003;138:525-33.
7. Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman SL. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001;108:1-7.
8. Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 2001;57:529-34.
9. Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A. Chouaid C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect 2003;53:177-82.
10. Geissler A, Gerbeaux P, Granier I, Blanc P, Facon K, Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 2003;29:49-54.
11. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis 2004;38:348-56.
12. Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau YR. Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 1999;32:239-49.
13. Hsueh PR, Liu CY, Luh KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 2002;8:132-7.
14. Chang SC, Hsieh WC, Liu CY. High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan. The Antibiotic Resistance Study Group of the Infectious Disease Society of the Republic of China. Diagn Microbiol Infect Dis 2000;36:107-12.
15. Ho M. Taiwan seeks to solve its resistance problems. Science 2001;291:2550-1.
16. Taiwan Bureau of National Health Insurance. Regulation No. 9003788. [in Chinese] http//www.nhi.gov.tw:8000/law/index.html (12 Jan. 2001).
17. Chen HM, Chung PW, Yu YJ, Tai WL, Kao WL, Chien YL, et al. Antimicrobial susceptibility of common bacterial pathogens isolated from a new regional hospital in southern Taiwan. Chang Gung Med J 2003;26:889-96.
18. Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalized patients at a Chinese university hospital. J Infect 2003;46:161-3.
19. McDonald LC, Yu HT, Yin HC, Hsiung AC, Ho M. Use and abuse of surgical antibiotic prophylaxis in hospitals in Taiwan. J Formos Med Assoc 2001;100:5-13.
20. Hermosilla Najera L, Canut Blasco A, Ulibarrena Sanz M, Abasolo Osinaga E, Abecia Inchaurregui LC. Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period. Pharmacoepidemiol Drug Saf 2003;12:243-7.
21. Buck CJ (2001) ICD-9-CM, volumes 1, 2, and 3. W. B. Saunders, Singapore, 2003. ISBN 981-4141-81-X.
22. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2004. http://www.whocc.no/atcddd (22 Feb. 2004).
23. WHO Collaborating Centre for Drug Statistics Methodology. About the ATC/DDD system. http://www/whocc.no.atcddd (22 Feb. 2004).
24. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. Jama 1996;275:234-40.
25. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999;43:459-65.
26. Gould IM. Antibiotic policies and control of resistance. Curr Opin Infect Dis 2002;15:395-400.
27. Bassetti M, Di Biagio A, Rebesco B, Cenderello G, Amalfitano ME, Bassetti D. Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int J Antimicrob Agents 2000;16:295-9.
28. Infection Control Committee. Antimicrobial Susceptibility Data for the Clinical Isolated Pathogens in the Year 2001 (July-December). Shin Kong Wu Ho-Su Memorial Hospital, Taipei, 2002.
29. Gonlugur U, Bakici MZ, Ozdemir L, Akkurt I, Icagasioglu S, Gultekin F. Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital. Ann Clin Microbiol Antimicrob 2003; 2:5.